ACA
LLY icon

Affinity Capital Advisors’s Eli Lilly LLY Stock Holding History

Affinity Capital Advisors’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.38M Sell
4,484
-115
-3% -$118K 0.66% 24
2026
Q1 		$4.23M Sell
4,599
-51
-1% -$51.7K 0.59% 26
2025
Q4 		$5M Buy
4,650
+1
+0% +$956 0.69% 25
2025
Q3 		$3.81M Sell
4,649
-200
-4% -$149K 0.59% 27
2025
Q2 		$3.78M Sell
4,849
-584
-11% -$454K 0.65% 28
2025
Q1 		$3.98M Sell
5,433
-80
-1% -$66.6K 0.79% 25
2024
Q4 		$4.26M Buy
5,513
+23
+0.4% +$19K 0.8% 26
2024
Q3 		$4.86M Sell
5,490
-311
-5% -$280K 0.94% 23
2024
Q2 		$5.25M Hold
5,801
– – 1.1% 21
2024
Q1 		$4.51M Sell
5,801
-231
-4% -$164K 1.01% 21
2023
Q4 		$3.52M Sell
6,032
-112
-2% -$65.4K 0.86% 30
2023
Q3 		$3.3M Buy
6,144
+28
+0.5% +$14.4K 0.91% 26
2023
Q2 		$2.87M Buy
6,116
+58
+1% +$24.3K 0.78% 28
2023
Q1 		$2.08M Hold
6,058
– – 0.65% 34
2022
Q4 		$2.22M Buy
6,058
+5
+0.1% +$1.77K 0.76% 29
2022
Q3 		$1.96M Buy
6,053
+468
+8% +$148K 0.68% 29
2022
Q2 		$1.81M Buy
5,585
+100
+2% +$30K 0.62% 29
2022
Q1 		$1.57M Hold
5,485
– – 0.49% 34
2021
Q4 		$1.51M Sell
5,485
-77
-1% -$19.5K 0.46% 37
2021
Q3 		$1.28M Hold
5,562
– – 0.43% 40
2021
Q2 		$1.28M Hold
5,562
– – 0.43% 40
2021
Q1 		$1.04M Sell
5,562
-100
-2% -$19.6K 0.38% 44
2020
Q4 		$956K Hold
5,662
– – 0.39% 44
2020
Q3 		$838K Sell
5,662
-500
-8% -$77.4K 0.47% 38
2020
Q2 		$1.01M Sell
6,162
-600
-9% -$92.1K 0.66% 29
2020
Q1 		$1.06M Sell
6,762
-200
-3% -$27.5K 0.78% 24
2019
Q4 		$915K Buy
+6,962
New +$807K 0.6% 28

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Affinity Capital Advisors's LLY Position: Q2 2026 in Review

Affinity Capital Advisors reduced its Eli Lilly (LLY) stake by 2.5% in Q2 2026, selling an estimated $118K and leaving 4,484 shares worth $5.38M. The position accounts for 0.66% of the portfolio, ranked #24.

Affinity Capital Advisors first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,602 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Affinity Capital Advisors held 4,484 shares of Eli Lilly worth $5.38M as of Q2 2026.
  • Affinity Capital Advisors sold 115 Eli Lilly shares in Q2 2026, an estimated $118K.
  • Eli Lilly made up 0.66% of Affinity Capital Advisors's portfolio in Q2 2026, its #24 holding.
  • Affinity Capital Advisors first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 4,602 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Affinity Capital Advisors's 13F filing for Q2 2026, filed 8 Jul 2026.